From the press release archive
Medicine 2024-01-26 1 min read

Clinical risk and outpatient therapy utilization for COVID-19 in the Medicare population

JAMA Health Forum
Published 2024-01-26 · Original archive entry · Explore research explainers
About The Study: In this study of patients enrolled in Medicare in 2022, those at the highest risk for severe COVID-19 infection received COVID-19 therapy less often than those with the least risk. Disparities in therapy access were found by patient age, race and ethnicity, Medicaid eligibility, and nursing home residence. 

Authors: Michael L. Barnett, M.D., of the Harvard T.H. Chan School of Public Health in Boston, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamahealthforum.2023.5044)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2023.5044?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=012624

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

END
From the original Press-News collection. Issuers of news releases are responsible for the accuracy of their content.